Tissue Engineering march-2021

March 30, 2021


We are delighted to announce the Upcoming Webinar on "Tissue Engineering" which is scheduled on March 30, 2021.  The webinar main theme focuses on “The future of Tissue Engineering”.The main aim of tissue engineering 2021 is to discuss the research, advanced techniques, improvements, treatment, and the most current updates in tissue engineering. This is your best chance to share your research and ideas, lead introductions, disseminate data, meet with present and potential specialists, make a splash with new improvements, and get name acknowledgment at this webinar.

Session-1: Tissue Engineering

It is an interdisciplinary field comprise of life sciences, bio-engineered materials and physiochemical factors which alters the health for betterment and personal satisfaction of individuals across the globe. It is a science of repair or replacement of damaged tissues or organs thus restoring the functioning of an organ. It employs natural or synthetic scaffolds to mimic the action of the human organs.

Session-2: Regenerative and Personalized Medicine

It is a novel field of therapeutic technique wherein personalized prescriptions or medications are provided to an individual. Pharmacogenomics and cellular therapy comprises together for the development of personalized therapy. The basis of regenerative medicines lies on the various forms of stems cells like, mesenchymal stem cells, pluripotent stem cells and embryonic stem cells which has a property of indefinite regeneration. Among the above mentioned the pluripotent stem cells are found to be a suitable candidate for personalized medicine.

Session-3: Bioartificial Organs

Tissue or engineered devices incorporated into the human body for replacement of a natural organ, interfacing with natural tissue are known as bioartificial organ. It combines biomaterials and biological cells for full replacement of patient failure organs. The commonly engineered bioartificial organs are bioartificial kidney devices, combining biomaterials and kidney epithelial cells for improved blood detoxification, bioartificial pancreas devices, combining encapsulation of pancreatic cells for treatment of diabetes, bioartificial lungs for studying lung regeneration.

Session-4: Stem Cell Engineering (SCE)

The remarkable improvement in the field of stem cell research has set the foundation for cell based treatments of disease which cannot be cured by conventional medicines. The capability of self-renewal and segregate into other forms of cells signify stem cells as borderlines of regenerative medicine. Progresses in gene editing and tissue engineering machinery have permitted the ex vivo remodeling of stem cells grown into 3D organoids and tissue structures for personalized uses.

Session-5: Cancer Stem Cells

The idea that cancer is primarily driven by a smaller population of stem cells has important implications.  They can divide and renovate themselves for long periods and are capable of give rise to specialised cells. They can therefore summarize tumour heterogeneity as they can be found in tumours. Research so far has proposed they also have multi drug and radiotherapy resistance. Hence there may be more similarities between cancer stem cells and normal stem cells.

  • Tissue Engineering
  • Regenerative and Personalized Medicine
  • Bioartificial Organs
  • Stem Cell Engineering (SCE)
  • Cancer Stem Cells

5 Renowned Speakers

Muhammad Alfath

Bandung Institute of Technology

N. C. Tolga EMRE

Bogazici University

Sunita Patel

Central University of Gujarat

Hyeonji Kim Pohang

University of Science and Technology
South Korea

Pamela Klecki

Karolinska Institute